Gelteq Limited (NASDAQ:GELS) Short Interest Update

Gelteq Limited (NASDAQ:GELS) was the target of a large growth in short interest in January. As of January 15th, there was short interest totaling 1,003,425 shares, a growth of 2,478.9% from the December 31st total of 38,909 shares. Based on an average daily trading volume, of 5,802,384 shares, the short-interest ratio is presently 0.2 days. Approximately 10.6% of the shares of the stock are sold short. Approximately 10.6% of the shares of the stock are sold short. Based on an average daily trading volume, of 5,802,384 shares, the short-interest ratio is presently 0.2 days.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Gelteq in a research note on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Gelteq presently has an average rating of “Sell”.

Institutional Investors Weigh In On Gelteq

An institutional investor recently bought a new position in Gelteq stock. Susquehanna International Group LLP bought a new position in Gelteq Limited (NASDAQ:GELS) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned approximately 0.44% of Gelteq at the end of the most recent quarter.

Gelteq Price Performance

Shares of NASDAQ:GELS traded up $0.04 during midday trading on Tuesday, reaching $1.03. 117,868 shares of the company were exchanged, compared to its average volume of 3,018,207. The business’s fifty day moving average is $0.97 and its two-hundred day moving average is $1.24. Gelteq has a one year low of $0.67 and a one year high of $4.11.

About Gelteq

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.